When was Arinna Lifesciences founded?

Arinna Lifesciences was founded in 2013 and raised its 1st funding round 2 years after it was founded.

Where is Arinna Lifesciences located?

Arinna Lifesciences is headquartered in Ahmedabad, India. It is registered at A- 301 TO 307, 3RD FLOOR, SANKALP ICONIC TOWER, ISKCON-AMBLI ROAD, OFF. S G HIGHWAY, Ahmedabad, AHMEDABAD, Gujarat, India, 380054.

Which legal entities is Arinna Lifesciences associated with?

Arinna Lifesciences is associated with ARINNA LIFESCIENCES LIMITED.

How many employees does Arinna Lifesciences have?

As of Aug 31, 2025, the latest employee count at Arinna Lifesciences is 305.

Is Arinna Lifesciences a funded company?

Arinna Lifesciences is a funded company, having raised a total of $11.8M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Feb 10, 2015.

How much is Arinna Lifesciences worth?

The last known valuation of Arinna Lifesciences was $***** as of Apr 03, 2026.

When was the latest funding round of Arinna Lifesciences?

Arinna Lifesciences' latest funding was a $***** Series A round on Jun 25, 2019, with participation from 2 investors.

What is the annual revenue of Arinna Lifesciences?

Annual revenue of Arinna Lifesciences is between ₹50 Cr and ₹100 Cr as on Mar 31, 2026

Where does Arinna Lifesciences rank among its competitors?

Arinna Lifesciences ranks 21st amongst 1054 active competitors, of which 30 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of Arinna Lifesciences?

Arinna Lifesciences' top competitors include Teva Pharmaceuticals, The Alvogen and Laboratorio Reig Jofre. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

Arinna Lifesciences - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Arinna Lifesciences an acquired company?

Arinna Lifesciences got acquired by Rubicon on Apr 15, 2026.

Arinna Lifesciences is an acquired company based in Ahmedabad (India), founded in 2013. It operates as a Developer and marketer of specialty pharmaceutical drugs for the central nervous system. Arinna Lifesciences has raised $11.8M in funding from Czar Group and Motilal Oswal, with last known valuation of $*****. The company has 1054 active competitors, including 30 funded and 290 that have exited. Its top competitors include companies like Teva Pharmaceuticals, The Alvogen and Laboratorio Reig Jofre.

Company Details

Developer and marketer of specialty pharmaceutical drugs for the central nervous system. It focuses on developing and marketing quality finished dosages. The company initially concentrates on central nervous system therapies, gradually expanding into other therapeutic areas. Its products address various conditions within the central nervous system. The company aims to provide meaningful and innovative medicines.

Website: arinnalifesciences.com
Phone Number: +91 **********
Registered Address: A- 301 TO 307, 3RD FLOOR, SANKALP ICONIC TOWER, ISKCON-AMBLI ROAD, OFF. S G HIGHWAY, Ahmedabad, AHMEDABAD, Gujarat, India, 380054

Key Metrics

Founded Year

2013

Location

Ahmedabad, India

Stage

Acquired

Total Funding

$11.8M in 5 rounds

Latest Funding Round

Series A, Jun 25, 2019, $*****

Last Known Valuation

$***** as on Apr 03, 2026

Investors

Czar Group & 7 more

Ranked

21^st among 1054 active competitors

Annual Revenue

₹50 - ₹100 Cr as on Mar 31, 2026

Employee Count

305 as on Aug 31, 2025

Similar Companies

Sentynl Therapeutics & 12 more

Exit Details

Acquired by Rubicon (Apr 15, 2026)

View Arinna Lifesciences' full profile

Arinna Lifesciences is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
ARINNA LIFESCIENCES LIMITED CIN: U24230GJ2013PLC076619 , India, Active	Aug 29, 2013	₹50 - ₹100 Cr (As on Mar 31, 2026)	289 (As on Mar 01, 2026)

Arinna Lifesciences got acquired by Rubicon on Apr 15, 2026 at an acquisition amount of $*****.

Click here to take a look at Arinna Lifesciences's acquisition in detail

Arinna Lifesciences has raised a total funding of $11.8M over 5 rounds. Its first funding round was on Feb 10, 2015. Its latest funding round was a Series A round on Jun 25, 2019 for $*****. 2 investors participated in its latest round. Arinna Lifesciences has 4 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Arinna Lifesciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 25, 2019	3273721	Series A	9788077	9404329	8957701	4541292
Jun 16, 2019	5307930	Series A	5989639	9648518	4822277	Vivek Seth & 1 more
Feb 15, 2018	2145764	Series A	1663630	9229708	Motilal Oswal	1494504

Access funding benchmarks and valuations. Sign up today!

View details of Arinna Lifesciences's funding rounds and investors

Arinna Lifesciences' Board of Directors

Arinna Lifesciences's board has 4 active members. Vivek Seth is part of team and Shankar Gopalakrishnan, Shilpa Vivek Seth and Siddharth Shah are independent board members.

Here is the list of Arinna Lifesciences' board of directors:

Name	Type	Representing	Status	Duration
Vivek Seth	Team	-	Current	13y 1m
Shankar Gopalakrishnan	Independent board member	-	Current	11y 5m
mgaraby	Independent board member	-	Current	6y 1m
vibhqxi	Independent board member	-	Current	2y 7m

Arinna Lifesciences' employee count trend

Arinna Lifesciences has 305 employees as of Aug 25. The total employee count is 5.0% lower than what it was in Aug 24. Here is Arinna Lifesciences's employee count trend over the years:

Employee count trend for Arinna Lifesciences

Uncover Arinna Lifesciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Arinna Lifesciences include Teva Pharmaceuticals, The Alvogen and Laboratorio Reig Jofre. Here is the list of Top 10 competitors of Arinna Lifesciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
2nd	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
3rd	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
4th	Hikma Pharmaceuticals 1978, London (United Kingdom), Public	Manufacturer of generic medicines and injectable pharmaceutical products for patients	-	Tekla Capital Management, Foursan Group & 1 others	67/100
5th	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	JPMorganChase, Ampersand Capital & 4 others	66/100
6th	Otsuka 1921, Minato (Japan), Public	Manufacturer of generic pharmaceuticals and nutraceuticals	-	Digital Pharma Lab, Gates	66/100
7th	Takeda 1781, Tokyo (Japan), Public	Large diversified pharma company	-	Digital Pharma Lab, Kleiner Perkins & 8 others	66/100
8th	Bausch & Lomb 1853, Bridgewater (United States), Public	Manufacturer of prescription pharmaceutical products and various eye care items	-	Welsh, Carson, Anderson & Stowe, Thomas, McNerney & Partners ... & 2 others	65/100
9th	Dexcel 1965, Hadera (Israel), Unfunded	Developer and manufacturer of branded and generic pharmaceutical products	-	-	64/100
10th	Inventia Healthcare 1985, Mumbai (India), Acquired	Manufacturer & developer of various oral solid oral drug delivery systems	$42.5M	Nylim-jb Asset Management, Jacob Ballas Capital ... & 7 others	63/100
21st	Arinna Lifesciences 2013, Ahmedabad (India), Acquired	Developer and marketer of specialty pharmaceutical drugs for the central nervous system	$11.8M	Motilal Oswal, Motilal Oswal Private Equity ... & 6 others	55/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Arinna Lifesciences's competitors? Click here to see the top ones

ARINNA LIFESCIENCES LIMITED, the legal entity associated with Arinna Lifesciences, generated between ₹50 Cr and ₹100 Cr in revenue for the financial year ending on Mar 31, 2026. The revenue of ARINNA LIFESCIENCES LIMITED has a compounded annual growth rate (CAGR) of 1% in the last 1 year.

Financial Statement Summary

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22
Income Statement
Revenue	1465	9129	2774	6477	3900
Total Sales	2902	2269	4167	6678	9641
Total Expenses	2160	9350	9035	8076	3882
Operating Expenses	2127	4394	8856	1784	5131
Employee Expenses	5234	7550	2408	2712	8696
Marketing Expenses	9254	7057	6375	2384	6585
Operating Income (EBIT)	2627	5136	2929	6247	2534
Interest Expenses	8354	5933	8607	8148	9917
Expenses from other activities	2242	7550	2231	4286	2307
Information Technology Expenses	5579	9622	9722	5722	2339
EBITDA	3322	3586	3331	6747	4895
Taxes	8089	9901	6783	6374	7435
Net Profit	6602	1438	6721	7944	1743
Balance Sheet
Assets	3808	1539	4272	6441	2776
Cash Equivalent	7951	2153	3994	1319	4873
Accounts Receivables	2523	2127	8523	7193	8044
Inventory	6772	7817	1222	2974	5724
Liabilities	5957	8608	2888	2912	7432
Total Debt	1909	8930	6892	3009	1999
Accounts Payable	9890	8334	6401	2500	5315
Equities	1351	1312	5940	4574	5277
Cashflow Statement
Cash from Operating activities	1569	2901	9057	6567	6387
Cash from Investing activities	8954	5911	6752	3979	2510
Net cash from Financing activities	8477	1388	1389	8049	6246

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Founders own 33.87%, Funds (largest shareholder) own 62.46%, Other People own 0.93% and ESOP Pool own 0.91%. The net worth of Arinna Lifesciences's founders is INR 55.4Cr as of Jun 25, 2019. The cap table displayed below is for ARINNA LIFESCIENCES LIMITED which is the legal entity associated with Arinna Lifesciences.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	33.87%	55.4Cr	1226289	5115286	9952231	7792685
Vivek Seth	6001322	6297981	1649728	9754807	3416112	3570136
Shilpa Vivek Seth	3648032	4553557	1386917	8389814	8495028	1294096
Fund	62.46%	102Cr	7564027	4864702	7031076	3360915
Czar Group	426	357	935	647	853	655
Other People	0.93%	1.52Cr	0	0	0	0
ESOP Pool	0.91%	1.48Cr	0	0	0	0
Other Investors	1.83%	3Cr	3	5	7	6
Total	100.00%	164Cr	5055350	7126086	9021750	9876906